MIRM
Mirum Pharmaceuticals
$100.61
+$2.31 (+2.35%)Sep 10, 2026
Key metrics
The numbers that frame MIRM today
- Market cap
- $6.53B
- P/E (TTM)
- -7.6
- EV / FCF
- -30.4
- Gross margin
- 81.7%
- EV / Sales
- 11.3
- ROIC
- -154.6%
- Div yield
- 0%
- 52wk Low
- $63.23
- 52wk High
- $130.00
Growth
Revenue and earnings trend for MIRM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about MIRM
Is Mirum Pharmaceuticals a good buy?
Hold. Mirum Pharmaceuticals has strong momentum, but weak quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Mirum Pharmaceuticals is selling at a high price.
What is the market capitalization of MIRM?
Mirum Pharmaceuticals's market capitalization is $6.53B.
What is the P/E ratio for MIRM stock?
Mirum Pharmaceuticals's current P/E ratio is -7.6.
What is the 52-week high for MIRM stock?
The 52-week high for Mirum Pharmaceuticals is $130.00. The current close of $100.61 is 22.6% below that high.
What is the 52-week low for MIRM stock?
The 52-week low for Mirum Pharmaceuticals is $63.23. The current close of $100.61 is 59.1% above that low.
Does MIRM stock pay dividends?
Mirum Pharmaceuticals does not currently show a dividend per share in the company data.